The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Initial Facilities

28 Feb 2014 07:02

RNS Number : 1830B
Rentokil Initial PLC
28 February 2014
 



 

 

 

28 February, 2014

 

Rentokil Initial announces the sale of Initial Facilities

 

Rentokil Initial plc (FTSE: RTO, "the Company") announces today that it has agreed the sale of its Initial Facilities ("IFS") business to Interserve Plc for a total cash consideration of £250m. Completion, which is subject to the agreement of Interserve's shareholders at a General Meeting on 17 March, is expected by the end of March 2014.

 

In 2013 Rentokil Initial indicated that Initial Facilities was a non-core business for the Company. Its disposal, following that of City Link last year, will enable Rentokil Initial to focus on its three core route-based categories of Pest Control, Hygiene and Workwear. Excluding Initial Facilities, the Company's total revenue for the year ended 31 December 2013 was £1.76bn.

 

Post disposal the underlying financial metrics of Rentokil Initial will be significantly enhanced:

 

*Actual 2013 (incl. IFS) Proforma 2013 (excl. IFS)

Net operating margin 11.2% 13.1%

Organic growth -1.2% +0.5%

APBITA growth +4.1% +6.4%

 

* (at Constant Exchange Rates)

 

Initial Facilities delivered adjusted operating profit of £25.8m on revenues of £534.0m for the year ended 31 December 2013. The business has gross assets of £229.6m.

 

Andy Ransom, Chief Executive of Rentokil Initial Plc, said:

 

"This transaction really is a 'win win win'. It is an excellent outcome for our colleagues and customers in Initial Facilities, it represents a great opportunity for Interserve and it is absolutely the right deal for Rentokil Initial and its shareholders.

 

"Proceeds from the sale will be used primarily to pay down debt. We are now in a terrific position to focus capital and resources on our core route-based categories of Pest Control, Hygiene and Workwear, and over time we will also look to make further acquisitions in these core businesses."

 

-- Ends --

 

Notes to Editors

 

Preliminary Results for the year ended 31 December 2013

 

A presentation for investors and analysts will be held on Friday 28 February 2014 at 8.45am at the Inmarsat Conference Centre, 99 City Road, London, EC1Y 1AX. This will be available via a live audio web cast at www.rentokil-initial.com.

 

 

 

Rentokil Initial:

 

Rentokil Initial is one of the largest business services companies in the world, operating in over 60 countries. The company offers route-based services including pest control, hygiene and workwear through teams of local experts.

 

www.rentokil-initial.com

 

 

 

Enquiries:

 

Investors / Analysts enquiries:

Katharine Rycroft, Investor Relations Rentokil Initial plc 07811 270 734

 

Media enquiries:

Malcolm Padley, Corporate Communications Rentokil Initial plc 07788 978 199

Justine McIlroy / Nina Coad / Oliver Hughes Brunswick Group 020 7404 5959

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DOCGDGDDCXDBGSI
Date   Source Headline
18th Oct 20179:25 amRNSHolding(s) in Company
16th Oct 201710:04 amRNSDirector/PDMR Shareholding
16th Oct 20177:30 amRNSStatement following recent media coverage
12th Oct 20173:46 pmRNSDirector/PDMR Shareholding
9th Oct 20177:00 amRNSInterserve wins Leeds housing development contract
6th Oct 20179:08 amRNSHolding(s) in Company
5th Oct 20178:50 amRNSHolding(s) in Company
3rd Oct 20172:15 pmRNSDirector/PDMR Shareholding
3rd Oct 20177:00 amRNSInterserve-led consortium chosen for £85m project
2nd Oct 20177:00 amRNSSection 430 (2B) Companies Act Statement
29th Sep 201711:33 amRNSHolding(s) in Company
27th Sep 20177:00 amRNSInterserve wins place on £8bn CMA framework
26th Sep 201710:49 amRNSHolding(s) in Company
26th Sep 201710:42 amRNSHolding(s) in Company
20th Sep 20179:03 amRNSHolding(s) in Company
19th Sep 20174:26 pmRNSHolding(s) in Company
19th Sep 20179:45 amRNSHolding(s) in Company
19th Sep 20177:00 amRNSHolding(s) in Company
18th Sep 20172:09 pmRNSDirector/PDMR Shareholding
18th Sep 20171:48 pmRNSHolding(s) in Company
18th Sep 201712:00 pmRNSDirector/PDMR Shareholding
18th Sep 201710:08 amRNSHolding(s) in Company
18th Sep 201710:04 amRNSHolding(s) in Company
18th Sep 20177:00 amRNSMark Whiteling appointed Chief Financial Officer
15th Sep 20173:33 pmRNSHolding(s) in Company
15th Sep 20172:16 pmRNSDirector/PDMR Shareholding
14th Sep 20177:00 amRNSTrading Update
13th Sep 20179:18 amRNSDirector/PDMR Shareholding
12th Sep 201711:44 amRNSDirector/PDMR Shareholding
12th Sep 201710:16 amRNSHolding(s) in Company
11th Sep 201711:13 amRNSHolding(s) in Company
6th Sep 20179:24 amRNSHolding(s) in Company
6th Sep 20177:00 amRNSInterserve wins £90m DfT FM contract
1st Sep 20177:00 amRNSSection 430 (2B) Companies Act Statement
29th Aug 201711:42 amRNSHolding(s) in Company
24th Aug 20174:27 pmRNSHolding(s) in Company
24th Aug 201710:42 amRNSHolding(s) in Company
24th Aug 20179:18 amRNSPublication of Half-Year Report
24th Aug 20178:46 amRNSHolding(s) in Company
17th Aug 20179:33 amRNSHolding(s) in Company
16th Aug 20177:00 amRNSInterserve and Amec Foster Wheeler Joint Venture
14th Aug 20172:17 pmRNSHolding(s) in Company
14th Aug 20172:16 pmRNSHolding(s) in Company
9th Aug 20173:01 pmRNSDirector/PDMR Shareholding
9th Aug 20177:00 amRNSHalf-Year Results 2017
13th Jul 20174:25 pmRNSDirector/PDMR Shareholding
12th Jul 201712:52 pmRNSDirector/PDMR Shareholding
12th Jul 20179:44 amRNSHolding(s) in Company
3rd Jul 20177:00 amRNSBlock listing Interim Review
30th Jun 20177:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.